Before Halloween, a few big income names have to prove their dividends are as solid as their yields look.

A parcel carrier paying 7% needs its cash flow to clear a $5.4 billion dividend bill, a chocolate maker near its 52-week low needs cheaper cocoa to rebuild margins, and a gas pipeline operator needs fresh contracts to keep its payout climbing.

Many investors overlook deductions that could help minimize capital gains tax, such as:

Each comes with IRS rules and reporting requirements.

That’s why consulting a fiduciary financial advisor is often recommended.

See Advisor Matches.

*This is not an offer to buy or sell any security or interest. All investing involves risk, including loss of principal. Working with an adviser may come with potential downsides such as payment of fees (which will reduce returns). Past performance is not a guarantee of future results. There are no guarantees that working with an adviser will yield positive returns. The existence of a fiduciary duty does not prevent the rise of potential conflicts of interest.

We do not manage client funds or hold custody of assets, we help users connect with relevant financial advisors.

Viatris Inc. (NASDAQ: VTRS) has agreed to acquire Pacira BioSciences for $1.65 billion, adding established non-opioid pain treatments including Exparel and Zilretta to its portfolio. The deal gives Viatris a larger position in treatments designed to reduce reliance on traditional opioid pain medicines.

Pacira also brings an existing commercial platform that Viatris can plug into its broader global reach, giving the company more branded products to grow alongside its large portfolio of generics and mature medicines.

Pain Treatment Gives the Company a Clearer Growth Area

Demand for alternatives to opioids has created room for medicines that can manage pain without relying on the same treatment approach. Pacira already has products positioned around that shift.

That makes pain management a more important part of your view of Viatris because the company is moving into an area where product differentiation matters more than simply competing on price.

Global Reach Could Make Pacira More Valuable

Pacira has built its business primarily around the U.S. market, while Viatris already sells medicines across a much broader international network. That distribution reach creates an opportunity to take existing products into more markets over time.

If those medicines gain wider adoption outside the U.S., you have a straightforward way to measure whether Viatris can use its global scale to make an acquired portfolio more valuable.

VTRS currently trades at $17 and pays a dividend of $0.48 per share, a yield of 2.81%.

Accenture plc (NYSE: ACN) has expanded its more than 20-year relationship with Dell by forming the Accenture Dell Business Group, a dedicated team focused on helping companies build and run AI on private and hybrid infrastructure. Accenture plans to train more than 3,000 professionals across Dell’s technology portfolio.

The move gives Accenture another way to stay involved after the strategy work ends, helping clients design, install, and modernize the infrastructure needed to run AI inside their own environments.

Dell Adds the Infrastructure Layer

Dell brings the servers, storage, and systems needed to run AI privately, while Accenture adds industry knowledge, implementation, and business transformation expertise. Together, they can offer clients more of the project under one relationship.

Private AI matters to your view of Accenture because those projects can pull consulting, infrastructure design, implementation, and long-term modernization into the same customer relationship.

The Relationship Can Last Beyond the Initial Build

AI infrastructure does not stop changing once it is installed. Companies still need upgrades, new models, security work, software integration, and changes to how employees use the systems.

As more companies keep sensitive AI workloads in-house, you have another reason to treat infrastructure execution as part of Accenture’s growth story, not just strategy advice.

ACN currently trades at $204 and pays a dividend of $6.84 per share, a yield of 3.33%.

America’s debt burden is climbing fast, and Elon Musk has warned that the country needs a major productivity breakthrough to change the trajectory.

A free guide breaks down the warning, the pressure it could put on traditional retirement assets, and one alternative strategy designed to reduce exposure to future turbulence.

See How to Prepare Your Retirement for America’s Debt Problem

Delta Air Lines, Inc. (NYSE: DAL) is facing another sharp rise in jet-fuel costs as higher oil prices put pressure on the airline industry. Unlike most of its competitors, however, Delta owns the Monroe Energy refinery in Pennsylvania, giving it a direct connection to the fuel supply behind its flights.

The refinery is expected to contribute about $700 million this year, making this unusual asset increasingly relevant as airlines manage one of their highest operating costs.

Owning a Refinery Changes the Fuel Equation

Most airlines buy the fuel they need and absorb whatever happens to market prices. Delta has another layer in the business because its refinery can benefit when refining economics strengthen.

Higher prices at the pump may shape your view of rising energy costs, but Delta experiences the same pressure on a far larger scale. Owning part of the fuel chain gives it something competitors generally do not have.

Fuel Strategy Matters Beyond One Quarter

Air travel demand can remain healthy while expensive fuel still makes every flight more costly to operate. That makes energy management an important part of Delta’s broader business strategy, not simply another expense line.

As fuel markets stay volatile, you have another reason to separate Delta from airlines that depend entirely on outside suppliers. Its refinery gives management one more tool when one of the industry’s costs suddenly moves against it.

DAL currently trades at $82 and pays a dividend of $0.86 per share, a yield of 1.05%.

Glacier Bancorp (GBCI) raised its quarterly dividend 6.1% to $0.35 per share from $0.33, a yield of about 3.3%.

National Health Investors (NHI) raised its quarterly dividend 2.2% to $0.94 per share from $0.92, a yield of about 5.8%.

Encompass Health (EHC) raised its quarterly dividend 10.5% to $0.21 per share from $0.19, a yield of about 0.7%.

Pershing Square (PS) cut its quarterly dividend 16% to $0.103 per share from $0.122, a yield of about 0.8% at the new rate.

Conagra Brands (CAG) cut its quarterly dividend 50% to $0.175 per share from $0.35, a yield of about 5.2% at the new rate.

Campbell's (CPB) cut its quarterly dividend 36% to $0.25 per share from $0.39, a yield of about 5.2% at the new rate.

Central banks have been accumulating gold while many Americans are asking the same question: what happens to retirement savings if the dollar keeps losing purchasing power?

A free new briefing looks at why gold has returned to the spotlight, what investors learned from the monetary changes of the 1970s, and where physical gold may fit in a long-term retirement plan.

It also explains one way eligible retirement savings can potentially be repositioned without an immediate tax hit.

Get the Free Gold Retirement Briefing and See Your Options

*Reagan Gold Group does not provide financial, legal, or tax advice. This information is for educational purposes only and should not be considered investment advice. All investments carry risk, including loss of principal. Past performance is not indicative of future results. Consult your licensed financial advisor before making investment decisions.